Newsletter | July 16, 2021

07.16.21 -- Decentralized Trials: A Blessing Or A Curse?

Is The Advent Of Decentralized Clinical Trials A Blessing Or A Curse?

Patients love decentralized trials, sponsors are embracing them, and clinical trial sites need to learn more. Here are some ways to adjust to this new era of clinical trials.

Teach The Mind By Inspiring The Heart

While many leaders have become fixated on improving their teams’ communications skills during COVID-19, they, instead, need to be focused on something quite different — something that is not always about the leader and the organization’s metrics.

Could The New Way Of Working More Virtually Offer Opportunities To Break The Silo Mentality That Exists Within Organizations?

See the answer from Jason Urban, Ph.D., who heads up Alexion Pharmaceuticals’ quality risk management function.

First-Time CEOs: Firsthand Tales Of The Good, The Bad, And The Ugly

Since the CEO position comes with such high expectations and stress, we thought it would be interesting to speak with three first-time CEOs to hear their tales of the good, the bad, and the ugly. In this executive virtual roundtable (EVR), perspectives are provided by Roger Crystal, CEO, Opiant Pharmaceuticals, Frank Lee, CEO, Forma Therapeutics, and Ivana Magovcevic-Liebisch, Ph.D., J.D., CEO, Vigil Neuroscience.

Web-Exclusive Content
3 Easy Ways To Implement Tech And Modernize Your Clinical Trial

The life sciences industry’s digital transformation has provided the tools to overcome many of the industry’s problems and has unlocked new avenues for the role of tech in clinical trials. Going forward, clinical executives can use tech in a multitude of ways to power clinical trials.

July 2021 Digital Edition

Inside you will find more on:

  • The Future Of Women's Health
  • Challenges Ahead For Life Sciences
  • Companies To Watch
  • CFOs In Pharma Are Changing

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.